Because, Mr. James, I wanted to ask, the regulator, he has to follow the law. How do you answer the question of higher costs?

I would say, since this is the first time, Congresswoman and Congressman Smith, that I have been at this table since the loss of our dear champion, I know that he is looking well at these hearings that you are holding.

I would like to see an initiation of some review.

But, in terms of your actual evaluation of Express Scripts-Medco merger, but other actions by these companies, many of them we know their names, who are PBMs, can't you initiate a review or an evaluation as to whether there is any…

Do we define small pharmacies in that legislation?

If we tried to glean all of the information, would you be able to provide data?

I think they have a valuable role, even as a small business, but as a familiar face to the community.

I believe that what we tried to do in the Affordable Care Act, close the doughnut hole, keep people alive who have preexisting diseases is a good thing.

I think there is an enormous amount of right on the side of community and small pharmacies. It is a mountain of rightness on that.

I think this was at the end of the term, and I think as you have listened to the questions in a Committee that is the protector of competition, it raises a concern on the issue of harm, when we give an exemption, who are we harming.

And the costs will be on the ultimate product that the consumer is coming to the pharmacy for.

I believe this is an important hearing that allows us to deal with this issue and be thoughtful, and see how we can come to a reasoned response.

we have to have a respectful balance.

If anyone has any information pursuant to this, please let me know.

I find it deeply concerning that this is called special treatment for the independent pharmacists.

the PBMs are just basically killing them, as far as no negotiation on the prices.

Yes. It is very well defined in there.

I think it is the responsibility of the FTC to look into those matters, not wait till we bring it to your attention.